Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe upper arm is one of three licensed injection sites for Mounjaro (tirzepatide), alongside the abdomen and thigh. Eli Lilly's prescribing information and the NHS tirzepatide guidance confirm that all three sites are suitable for the weekly subcutaneous injection, provided you rotate between them. Choosing the arm is perfectly valid and, for many people, simply practical — though the technique matters more than most realise. Mounjaro is a prescription-only medicine; a prescriber assesses whether it's clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's Summary of Product Characteristics (SmPC), accessible via the electronic Medicines Compendium (eMC), lists the abdomen, thigh and upper arm as the three approved subcutaneous sites. This wasn't arbitrary. Subcutaneous tissue in all three areas has well-established blood-flow characteristics that allow a once-weekly depot injection to be absorbed steadily. Pharmacokinetic data from the SURMOUNT clinical programme showed consistent systemic exposure across injection sites, which is why rotation is endorsed rather than just permitted.
One thing worth setting straight: some people assume the arm gives faster or stronger results because it's "closer to the bloodstream." There's no clinical basis for this. Peak plasma concentration and overall absorption are comparable across all three licensed sites. What does differ is fat-layer thickness, which varies between individuals and affects how easy it is to administer a clean subcutaneous injection at each location.
If you want to understand the full landscape of all licensed Mounjaro injection sites before settling on a routine, that overview is a useful starting point.
The outer, lower portion of the upper arm (the tricep area) is the recommended zone, and our guide to the Mounjaro arm injection site goes into detail on exactly where to place the pen and how to position your arm comfortably. The inner arm and the deltoid are not listed, and the skin there tends to be thinner with less subcutaneous fat. Pinching a fold of skin before injecting helps ensure the needle reaches fat rather than muscle, which matters for both comfort and reliable absorption.
Self-injection into this site is feasible but genuinely trickier than the abdomen. Reaching the back of your own arm at the right angle, while pinching skin, requires some flexibility. Many people manage with practice; others find a second pair of hands useful at the start. The KwikPen's design (a pre-filled device that delivers all four weekly doses in sequence) means you're pressing the pen flat against the skin rather than manipulating a separate syringe, which helps.
Needle length is a practical consideration here. Subcutaneous fat in the arm can be shallower than at the abdomen, particularly in people who have already lost significant weight. Shorter needles tend to suit the arm site well for this reason. Using smaller needles with Mounjaro explains the options in more detail, including what gauges are available and what prescribers generally advise.
Cleaning the site beforehand with an alcohol swab and allowing it to dry completely before injecting reduces the risk of stinging and skin reactions. Alcohol swabs are available from our pharmacy if you need them alongside your treatment.
The NHS guidance on tirzepatide is explicit: do not inject into the same spot twice in a row. Repeated injection into one small area can cause lipodystrophy (a localised thickening or indentation of subcutaneous tissue) which disrupts absorption and can be uncomfortable. Rotating between the arm, abdomen and thigh from week to week (and varying the precise spot within each area) prevents this.
A straightforward way to build a habit: many people keep a simple note on their phone logging which site they used each week. It takes three seconds and removes the need to rely on memory. If you're also using the thigh as a site, alternating arm and thigh works well when the abdomen is temporarily unavailable (for example, around surgery or skin irritation).
Injection-site reactions (mild redness, itching or a small bump at the injection point) are listed as common side effects across all three sites. These typically resolve within a few hours to a couple of days. If a reaction is more severe, persists, or is accompanied by pain spreading away from the injection point, your prescriber needs to know. You can report unexpected side effects through the MHRA's Yellow Card scheme.
Injection technique is one of those things that looks straightforward in a diagram and takes a couple of attempts to feel natural in practice. Our prescribers cover it during the clinical review — not as an afterthought, but because it genuinely affects how comfortable and effective the treatment is week to week. If something doesn't feel right about how you're injecting into your arm, that's a clinical conversation, not an embarrassing one.
For anyone considering Mounjaro for weight management, our Mounjaro overview covers the licensed indications, eligibility and what the treatment programme involves. Broader weight loss treatment options are outlined if you're still weighing up which approach suits your situation. Cost is often a factor people want to understand early; a plain-language breakdown of what private tirzepatide typically costs is on our Mounjaro cost page.
If you're ready to find out whether you'd be clinically suitable, check your eligibility with a free consultation. A GPhC-registered prescriber reads every response, no automated decisions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.